Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Acromegaly Clinical Manifestations and Management

Introduction to Acromegaly

  • Acromegaly presents with a wide range of clinical manifestations including characteristic somatic disfigurement, systemic manifestations, and metabolic dysfunction, all resulting from excess growth hormone (GH) and insulin-like growth factor I (IGF-I) levels 1

Cardiovascular Complications

  • Heart failure is the most common cause of death in untreated acromegaly 2, 3
  • Valvular heart disease is a specific complication 3
  • Left ventricular hypertrophy may occur and can improve with treatment 3

Clinical Implications

  • Elevated GH and IGF-I levels are predictors of mortality in acromegaly patients 1, 2
  • Normalizing GH and IGF-I levels through treatment results in mortality rates similar to the general population 1, 2
  • Regular colonoscopic screening is recommended starting at age 40 due to increased risk of colorectal neoplasia 3, 4

Diagnostic Confirmation

  • Biochemical confirmation is essential through elevated IGF-I levels and failure to suppress GH during an oral glucose tolerance test 2

REFERENCES

2

Diagnosis and Biochemical Confirmation of Acromegaly [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Mortality and Morbidity in Acromegaly [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Screening and Treatment Recommendations for Acromegaly [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025